3212
A. Fernández-Mateos et al.
LETTER
(CH2), 36.37 (CH), 38.15 (C), 38.68 (CH2), 39.46 (CH),
40.92 (CH), 55.32 (C), 72.69 (CH), 72.76 (CH2), 79.34
(CH2) ppm.
1H NMR (400 MHz, CDCl3): d = 0.90 (3 H, s), 1.21 (3 H, s),
1.66 (4 H, m), 1.90 (1 H, m), 1.98 (1 H, t, J = 5.8 Hz), 2.10–
2.60 (4 H, m), 3.93 (1 H, t, J = 6.1 Hz), 4.68 (1 H, dd,
J1 = 9.2 Hz, J2 = 5.4 Hz) ppm. 13C NMR (100 MHz, CDCl3):
d = 22.62 (CH2), 23.16 (CH3), 27.49 (CH3), 27.85 (CH2),
29.90 (CH2), 38.35 (CH2, C), 40.76 (CH), 53.12 (CH, C),
62.02 (CH), 74.68 (CH) ppm. MS (EI): m/z (%) = 177 (3)
[M+ – 19], 163 (3), 149 (13), 134 (14), 121 (3), 108 (35), 92
(72), 91 (100), 67 (23), 55 (23). HRMS (EI): m/z calcd for
C12H20O2Na [M+ + Na]: 219.1356; found: 219.1338. Mp
146–150 °C; [a]D20 –7.4 (c 0.6, CHCl3).
Compound 11: IR: 3400, 1645 cm–1. 1H NMR (400 MHz,
CDCl3): d = 1.76 (3 H, s), 1.80–2.50 (5 H, m), 4.01 (1 H, m),
4.03 (2 H, s), 4.29 (1 H, s), 4.73 (1 H, s), 4.75 (1 H, s), 5.19
(1 H, d, J = 10.4 Hz), 5.27 (1 H, d, J = 15.6 Hz), 5.87 (1 H,
br s), 5.89 (1 H, m) ppm. 13C NMR (100 MHz, CDCl3):
d = 20.87 (CH3), 30.86 (CH2), 30.15 (CH), 35.57 (CH2),
60.30 (CH), 71.38 (CH2), 74.45 (CH2), 109.03 (CH2), 117.24
(CH2), 129.49 (CH), 134.34 (CH), 134.94 (C), 149.01 (C)
ppm. MS (EI): m/z (%) = 150 (22) [M+ – 58], 135 (20), 131
(13), 108 (69), 93 (68), 91 (100), 68 (79), 55 (98). HRMS
(EI): m/z calcd for C13H20O2Na [M+ + Na]: 231.1355; found:
231.1353; [a]D20 –49.2 (c 1.3, CHCl3).
Compound 16a2: IR: n = 3445, 2929, 1453, 1260, 1051 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.81 (3 H, s), 1.29 (3 H, s),
1.44 (2 H, m), 1.60–1.90 (4 H, m), 2.09 (1 H, m), 2.34 (2 H,
m), 2.46 (1 H, m), 3.94 (1 H, d, J = 8.2 Hz), 4.69 (1 H, dd,
J1 = 10.4 Hz, J2 = 10.4 Hz) ppm. 13C NMR (100 MHz,
CDCl3): d = 23.04 (CH3), 26.44 (CH2), 27.00 (CH3, CH2),
27.71 (CH2), 38.81 (CH2), 39.50 (CH), 39.54 (C), 43.99
(CH), 55.52 (C), 69.39 (CH), 71.48 (CH) ppm. MS (EI):
m/z (%) = 163 (3) [M+ – 33], 163 (2), 149 (1), 134 (10), 121
(4), 117 (27), 92 (51), 91 (100), 70 (23), 55 (43). HRMS (EI):
m/z calcd for C12H20O2Na [M+ + Na]: 219.1356; found:
219.1344. Mp 166–168 °C; [a]D20 +33.5 (c 0.7, CHCl3).
Compound 17c: IR: 3383, 2923, 2858, 1729, 1469, 1391,
1372 cm–1. 1H NMR (400 MHz, CDCl3): d = 0.89 (3 H, d,
J = 6.6 Hz), 0.91 (3 H, d, J = 6.6 Hz), 1.20–2.20 (12 H, m),
2.44 (2 H, t, J = 8.9 Hz), 4.05 (1 H, br s), 5.56 (1 H, m), 9.77
(1 H, s) ppm. 13C NMR (100 MHz, CDCl3): d = 19.45 (CH3),
19.89 (CH3), 21.78 (CH2), 27.55 (CH2), 28.99 (CH2), 31.94
(CH), 33.99 (CH2), 34.06 (CH), 35.48 (CH2), 43.71 (CH2),
67.13 (CH), 125.69 (CH), 137.92 (C), 202.57 (CH) ppm. MS
(EI): m/z (%) = 206 (9) [M+ – 18], 188 (3), 163 (9), 153 (13),
145 (33), 121 (12), 117 (29), 93 (35), 91 (100), 67 (67), 55
(90). HRMS (EI): m/z calcd for C14H24O2Na [M+ + Na]:
247.1674; found: 247.1681; [a]D20 –51.9 (c 2.1, CHCl3).
Compound 20d: IR: 3407, 2927, 1729, 1457, 1247, 1040
cm–1. 1H NMR (400 MHz, CDCl3): d = 1.73 (3 H, s), 1.50–
2.40 (5 H, m), 2.07 (3 H, s), 4.20 (1 H, br s), 4.51 (1 H, d,
J = 6.2 Hz), 4.72 (1 H, s), 4.73 (1 H, d, J = 6.2 Hz), 4.75 (1
H, s), 5.94 (1 H, br s) ppm. 13C NMR (100 MHz, CDCl3):
d = 20.78 (CH3), 20.94 (CH3), 30.80 (CH2), 34.99 (CH),
35.99 (CH2), 64.78 (CH), 66.58 (CH2), 109.27 (CH2), 130.74
(CH), 133.76 (C), 148.61 (C), 171.11 (C) ppm. MS (EI):
m/z (%) = 192 (2) [M+ – 18], 167 (1), 150 (25), 132 (20), 117
(96), 91 (100), 68 (50), 53 (70). HRMS (EI): m/z calcd for
Compound 13a1: IR: 3451, 2928, 2899, 1761, 1252, 1042
cm–1. 1H NMR (400 MHz, CDCl3): d = 0.96 (3 H, s), 1.13 (1
H, d, J = 10.2 Hz), 1.21 (3 H, s), 1.64 (2 H, m), 1.94 (1 H,
m), 2.24 (1 H, t, J = 5.7 Hz), 2.33 (1 H, m), 2.56 (2 H, m),
2.70 (1 H, m), 3.03 (1 H, m), 4.59 (1 H, dd, J1 = 9.3 Hz,
J2 = 4.9 Hz) ppm. 13C NMR (100 MHz, CDCl3): d = 18.56
(CH2), 23.35 (CH3), 27.07 (CH3), 29.82 (CH2), 38.35 (CH2),
38.53 (C), 40.44 (CH), 41.63 (CH2), 50.24 (CH), 62.53
(CH), 75.80 (C), 212.49 (C) ppm. MS (EI): m/z (%) = 179
(2) [M+ – 15], 161 (2), 134 (4), 133 (17), 119 (26), 105 (100),
91 (96), 77 (30), 67 (28), 55 (68). HRMS (EI): m/z calcd for
C12H18O2Na [M+ + Na]: 217.1199; found: 217.1206; [a]D
–10.1 (c 1.4, CHCl3).
20
Compound 13a2: IR: n = 3451, 2928, 2894, 1765, 1217 cm–1.
1H NMR (200 MHz, CDCl3): d = 0.87 (3 H, s), 1.20 (1 H, d,
J = 10.1 Hz), 1.28 (3 H, s), 1.50–2.40 (6 H, m), 2.54 (1 H,
m), 3.01 (2 H, t, J = 8.9 Hz), 4.38 (1 H, dd, J1 = 9.1 Hz,
J2 = 3.7 Hz) ppm. 13C NMR (100 MHz, CDCl3): d = 22.65
(CH3), 26.59 (CH3), 27.16 (CH2), 27.88 (CH2), 39.16 (CH2),
39.65 (C), 39.80 (CH), 42.98 (CH2), 48.56 (CH), 53.40 (C),
70.61 (CH), 213.39 (C) ppm. MS (EI): m/z (%) = 179 (3) [M+
– 15], 151 (3), 134 (6), 133 (24), 119 (26), 105 (100), 91
(80), 77 (40), 67 (42), 55 (89). HRMS (EI): m/z calcd for
C12H18O2Na [M+ + Na]: 217.1199; found: 217.1195; [a]D
+40.7. (c 1.9, CHCl3).
20
Compound 14a: IR: n = 3455, 2920, 2249, 1645, 1441, 1217,
1053 cm–1. 1H NMR (400 MHz, CDCl3): d = 1.62 (1 H, dt,
J1 = 4.0 Hz, J2 = 13.3 Hz), 1.73 (3 H, s), 1.90 (4 H, m), 2.10–
2.60 (4 H, m), 4.09 (1 H, br s), 4.72 (1 H, s), 4.75 (1 H, s),
5.73 (1 H, m) ppm. 13C NMR (100 MHz, CDCl3): d = 16.71
(CH2), 20.82 (CH3), 30.47 (CH2), 30.81 (CH2), 35.04 (CH),
36.85 (CH2), 66.90 (CH), 109.37 (CH2), 119.73 (C), 128.03
(CH), 134.77 (C), 148.52 (C) ppm. MS (EI): m/z (%) = 173
(6) [M+ – 18], 158 (6), 131 (9), 117 (22), 105 (21), 91 (100),
77 (23), 65 (22), 51 (23); HRMS (EI): m/z calcd for
C12H17NONa [M+ + Na]:214.1208; found: 214.1205.
Compound 16a1: IR: n = 3439, 2929, 1455, 1260, 1052 cm–1.
20
C12H18O3Na [M+ + Na]: 233.1148; found: 233.1161; [a]D
–108.5 (c 0.3, CHCl3).
(9) Yamamoto, Y.; Matsumi, D.; Hattori, R.; Itoh, K. J. Org.
Chem. 1999, 64, 3224.
(10) Cuerva, J. M.; Campaña, A. G.; Justicia, J.; Rosales, A.;
Oller-López, J. L.; Robles, R.; Cárdenas, D. J.; Buñuel, E.;
Oltra, J. E. Angew. Chem. 2006, 118, 5522.
Synlett 2008, No. 20, 3208–3212 © Thieme Stuttgart · New York